Literature DB >> 30742034

PSMA ADC shows promise in advanced disease.

Louise Stone1.   

Abstract

Entities:  

Year:  2019        PMID： 30742034     DOI： 10.1038/s41585-019-0161-y

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.

Authors:  Daniel P Petrylak; Philip Kantoff; Nicholas J Vogelzang; Anthony Mega; Mark T Fleming; Joe J Stephenson; Richard Frank; Neal D Shore; Robert Dreicer; Edward F McClay; William R Berry; Manish Agarwal; Vincent A DiPippo; Yakov Rotshteyn; Nancy Stambler; William C Olson; Stephen A Morris; Robert J Israel
Journal:  Prostate       Date:  2019-01-20       Impact factor: 4.104
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.